Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement

Background Hypertrophic cardiomyopathy (HCM) and aortic stenosis can cause obstruction to the flow of blood out of the left ventricular outflow tract into the aorta, with obstructive HCM resulting in dynamic left ventricular outflow tract obstruction and moderate or severe aortic stenosis causing fi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Milind Y. Desai, Alaa Alashi, Zoran B. Popovic, Per Wierup, Brian P. Griffin, Maran Thamilarasan, Douglas Johnston, Lars G. Svensson, Harry M. Lever, Nicholas G. Smedira
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/68abe387f18349329ca2d1d668e41572
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:68abe387f18349329ca2d1d668e41572
record_format dspace
spelling oai:doaj.org-article:68abe387f18349329ca2d1d668e415722021-11-23T11:36:35ZOutcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement10.1161/JAHA.120.0184352047-9980https://doaj.org/article/68abe387f18349329ca2d1d668e415722021-09-01T00:00:00Zhttps://www.ahajournals.org/doi/10.1161/JAHA.120.018435https://doaj.org/toc/2047-9980Background Hypertrophic cardiomyopathy (HCM) and aortic stenosis can cause obstruction to the flow of blood out of the left ventricular outflow tract into the aorta, with obstructive HCM resulting in dynamic left ventricular outflow tract obstruction and moderate or severe aortic stenosis causing fixed obstruction caused by calcific degeneration. We sought to report the characteristics and longer‐term outcomes of patients with severe obstructive HCM who also had concomitant moderate or severe aortic stenosis requiring surgical myectomy and aortic valve replacement. Methods and Results We studied 191 consecutive patients (age 67±6 years, 52% men) who underwent myectomy and aortic valve (AV) replacement (90% bioprosthesis) at our center between June 2002 and June 2018. Clinical and echo data including left ventricular outflow tract gradient and indexed AV area were recorded. The primary outcome was death. Prevalence of hypertension (63%) and hyperlipidemia (75%) were high, with a Society of Thoracic Surgeons score of 5±4, and 70% of participants had no HCM‐related sudden death risk factors. Basal septal thickness and indexed AV area were 1.9±0.4 cm and 0.72±0.2 cm2/m2, respectively, while 100% of patients had dynamic left ventricular outflow tract gradient >50 mm Hg. At 6.5±4 years, 52 (27%) patients died (1.5% in‐hospital deaths). One‐, 2‐, and 5‐year survival in the current study sample was 94%, 91%, and 83%, respectively, similar to an age‐sex–matched general US population. On multivariate Cox survival analysis, age (hazard ratio [HR], 1.65; 95% CI, 1.24–2.18), chronic kidney disease (HR, 1.58; 95% CI, 1.21–2.32), and right ventricular systolic pressure on preoperative echocardiography (HR, 1.28; 95% CI, 1.05–1.57) were associated with longer‐term mortality, but traditional HCM risk factors did not. Conclusions In symptomatic patients with severely obstructive HCM and moderate or severe aortic stenosis undergoing a combined surgical myectomy and AV replacement at our center, the observed postoperative mortality was significantly lower than the expected mortality, and the longer‐term survival was similar to a normal age‐sex–matched US population.Milind Y. DesaiAlaa AlashiZoran B. PopovicPer WierupBrian P. GriffinMaran ThamilarasanDouglas JohnstonLars G. SvenssonHarry M. LeverNicholas G. SmediraWileyarticleaortic stenosishypertrophic cardiomyopathysurgery and outcomesDiseases of the circulatory (Cardiovascular) systemRC666-701ENJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 18 (2021)
institution DOAJ
collection DOAJ
language EN
topic aortic stenosis
hypertrophic cardiomyopathy
surgery and outcomes
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle aortic stenosis
hypertrophic cardiomyopathy
surgery and outcomes
Diseases of the circulatory (Cardiovascular) system
RC666-701
Milind Y. Desai
Alaa Alashi
Zoran B. Popovic
Per Wierup
Brian P. Griffin
Maran Thamilarasan
Douglas Johnston
Lars G. Svensson
Harry M. Lever
Nicholas G. Smedira
Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement
description Background Hypertrophic cardiomyopathy (HCM) and aortic stenosis can cause obstruction to the flow of blood out of the left ventricular outflow tract into the aorta, with obstructive HCM resulting in dynamic left ventricular outflow tract obstruction and moderate or severe aortic stenosis causing fixed obstruction caused by calcific degeneration. We sought to report the characteristics and longer‐term outcomes of patients with severe obstructive HCM who also had concomitant moderate or severe aortic stenosis requiring surgical myectomy and aortic valve replacement. Methods and Results We studied 191 consecutive patients (age 67±6 years, 52% men) who underwent myectomy and aortic valve (AV) replacement (90% bioprosthesis) at our center between June 2002 and June 2018. Clinical and echo data including left ventricular outflow tract gradient and indexed AV area were recorded. The primary outcome was death. Prevalence of hypertension (63%) and hyperlipidemia (75%) were high, with a Society of Thoracic Surgeons score of 5±4, and 70% of participants had no HCM‐related sudden death risk factors. Basal septal thickness and indexed AV area were 1.9±0.4 cm and 0.72±0.2 cm2/m2, respectively, while 100% of patients had dynamic left ventricular outflow tract gradient >50 mm Hg. At 6.5±4 years, 52 (27%) patients died (1.5% in‐hospital deaths). One‐, 2‐, and 5‐year survival in the current study sample was 94%, 91%, and 83%, respectively, similar to an age‐sex–matched general US population. On multivariate Cox survival analysis, age (hazard ratio [HR], 1.65; 95% CI, 1.24–2.18), chronic kidney disease (HR, 1.58; 95% CI, 1.21–2.32), and right ventricular systolic pressure on preoperative echocardiography (HR, 1.28; 95% CI, 1.05–1.57) were associated with longer‐term mortality, but traditional HCM risk factors did not. Conclusions In symptomatic patients with severely obstructive HCM and moderate or severe aortic stenosis undergoing a combined surgical myectomy and AV replacement at our center, the observed postoperative mortality was significantly lower than the expected mortality, and the longer‐term survival was similar to a normal age‐sex–matched US population.
format article
author Milind Y. Desai
Alaa Alashi
Zoran B. Popovic
Per Wierup
Brian P. Griffin
Maran Thamilarasan
Douglas Johnston
Lars G. Svensson
Harry M. Lever
Nicholas G. Smedira
author_facet Milind Y. Desai
Alaa Alashi
Zoran B. Popovic
Per Wierup
Brian P. Griffin
Maran Thamilarasan
Douglas Johnston
Lars G. Svensson
Harry M. Lever
Nicholas G. Smedira
author_sort Milind Y. Desai
title Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement
title_short Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement
title_full Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement
title_fullStr Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement
title_full_unstemmed Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement
title_sort outcomes in patients with obstructive hypertrophic cardiomyopathy and concomitant aortic stenosis undergoing surgical myectomy and aortic valve replacement
publisher Wiley
publishDate 2021
url https://doaj.org/article/68abe387f18349329ca2d1d668e41572
work_keys_str_mv AT milindydesai outcomesinpatientswithobstructivehypertrophiccardiomyopathyandconcomitantaorticstenosisundergoingsurgicalmyectomyandaorticvalvereplacement
AT alaaalashi outcomesinpatientswithobstructivehypertrophiccardiomyopathyandconcomitantaorticstenosisundergoingsurgicalmyectomyandaorticvalvereplacement
AT zoranbpopovic outcomesinpatientswithobstructivehypertrophiccardiomyopathyandconcomitantaorticstenosisundergoingsurgicalmyectomyandaorticvalvereplacement
AT perwierup outcomesinpatientswithobstructivehypertrophiccardiomyopathyandconcomitantaorticstenosisundergoingsurgicalmyectomyandaorticvalvereplacement
AT brianpgriffin outcomesinpatientswithobstructivehypertrophiccardiomyopathyandconcomitantaorticstenosisundergoingsurgicalmyectomyandaorticvalvereplacement
AT maranthamilarasan outcomesinpatientswithobstructivehypertrophiccardiomyopathyandconcomitantaorticstenosisundergoingsurgicalmyectomyandaorticvalvereplacement
AT douglasjohnston outcomesinpatientswithobstructivehypertrophiccardiomyopathyandconcomitantaorticstenosisundergoingsurgicalmyectomyandaorticvalvereplacement
AT larsgsvensson outcomesinpatientswithobstructivehypertrophiccardiomyopathyandconcomitantaorticstenosisundergoingsurgicalmyectomyandaorticvalvereplacement
AT harrymlever outcomesinpatientswithobstructivehypertrophiccardiomyopathyandconcomitantaorticstenosisundergoingsurgicalmyectomyandaorticvalvereplacement
AT nicholasgsmedira outcomesinpatientswithobstructivehypertrophiccardiomyopathyandconcomitantaorticstenosisundergoingsurgicalmyectomyandaorticvalvereplacement
_version_ 1718416768958988288